SCICLONE PHARMACEUTICALS INC·4

Feb 21, 6:42 PM ET

Li Simon 4

4 · SCICLONE PHARMACEUTICALS INC · Filed Feb 21, 2013

Insider Transaction Report

Form 4
Period: 2013-01-10
Li Simon
Director
Transactions
  • Award

    Non-Qualified Stock Option (right to buy)

    2013-01-10+50,00050,000 total
    Exercise: $4.85Exp: 2023-01-10Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]Granted under the Issuer's 2004 Outside Directors Stock Option Plan.
  • [F2]Shares shall become exercisable in three equal annual installments beginning on the first anniversary of the date of grant, subject to the Outside Director's continuous service on Issuer's Board of Directors.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT